title: The influence of HLA matching in cardiac allograft recipients receiving cyclosporine and azathioprine.
authors.affiliation: Harefield Hospital, Middlesex, England.
authors.forename: M
authors.initials: M
authors.lastname: Yacoub
authors.forename: H
authors.initials: H
authors.lastname: Festenstein
authors.forename: P
authors.initials: P
authors.lastname: Doyle
authors.forename: M
authors.initials: M
authors.lastname: Martin
authors.forename: D
authors.initials: D
authors.lastname: McCloskey
authors.forename: J
authors.initials: J
authors.lastname: Awad
authors.forename: A
authors.initials: A
authors.lastname: Gamba
authors.forename: A
authors.initials: A
authors.lastname: Khaghani
authors.forename: J
authors.initials: J
authors.lastname: Holmes
mesh_terms: D001379:Azathioprine / Q000627:therapeutic use*; D001788:Blood Grouping and Crossmatching; D003524:Cyclosporins / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology*; D015395:Histocompatibility Antigens Class I / Q000032:analysis; D000949:Histocompatibility Antigens Class II / Q000032:analysis; D006650:Histocompatibility Testing; D006801:Humans; D014184:Transplantation, Homologous
chemical_list: D003524:Cyclosporins; D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II; D001379:Azathioprine